ARMISTICE CAPITAL, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q4 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2021$23,457,000
-50.3%
2,348,000
-5.0%
0.38%
-52.0%
Q3 2021$47,240,000
-19.5%
2,472,000
+34.6%
0.80%
-23.9%
Q2 2021$58,715,000
-0.8%
1,836,000
-6.5%
1.05%
-22.7%
Q1 2021$59,215,000
+55.9%
1,964,000
+123.7%
1.36%
+5.3%
Q4 2020$37,991,000
-12.0%
878,000
+9.8%
1.29%
-17.5%
Q3 2020$43,160,000
+24.5%
800,000
+40.8%
1.57%
+3.0%
Q2 2020$34,671,000
+16.4%
568,000
-12.3%
1.52%
-17.4%
Q1 2020$29,782,000
+1.0%
648,000
+92.9%
1.84%
+8.3%
Q4 2019$29,484,000
+131.8%
336,000
+236.0%
1.70%
+112.1%
Q2 2019$12,720,000
+18.9%
100,000
+47.1%
0.80%
+36.9%
Q1 2019$10,698,000
-16.7%
68,000
-22.7%
0.59%
-24.0%
Q3 2018$12,848,000
-54.5%
88,000
-51.1%
0.77%
-58.2%
Q2 2018$28,251,000
+175.8%
180,000
+200.0%
1.84%
+135.3%
Q1 2018$10,245,000
+64.3%
60,000
+71.4%
0.78%
+26.0%
Q4 2017$6,234,000
+19.4%
35,000
-7.9%
0.62%
+1.1%
Q3 2017$5,219,000
+77.5%
38,000
+35.7%
0.62%
+64.0%
Q2 2017$2,941,000
+34.8%
28,000
+16.7%
0.38%
-16.9%
Q1 2017$2,182,000
-11.6%
24,000
-40.0%
0.45%
-22.8%
Q4 2016$2,468,000
-40.6%
40,000
-58.3%
0.58%
-63.1%
Q2 2016$4,156,00096,0001.58%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2019
NameSharesValueWeighting ↓
Bullseye Asset Management LLC 157,872$5,049,0001.70%
Sessa Capital IM, L.P. 1,200,000$38,376,0001.44%
Birchview Capital, LP 74,000$2,367,0001.42%
Bain Capital Life Sciences Investors, LLC 538,179$17,211,0001.13%
ARMISTICE CAPITAL, LLC 1,836,000$58,715,0001.05%
Parametrica Management Ltd 43,412$1,387,0001.02%
Tarsadia Capital, LLC 100,000$3,198,0000.90%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,252,575$40,057,0000.60%
MANGROVE PARTNERS IM, LLC 151,173$4,835,0000.50%
Quinn Opportunity Partners LLC 215,000$6,876,0000.43%
View complete list of BLUEBIRD BIO INC shareholders